Work

Brentuximab Vedotin Improves HCT-CI, CR Status, and Peri-Transplant Toxicity In Patients With Relapsed/Refractory Hodgkin Lymphoma Heading To RIC Allo-HCT

Year: 2013

Type: article

Study design: Observational Study

Source: Blood

DOI: 10.1182/blood.v122.21.3374.3374

Authors: Robert Chen, Joycelynne Palmer, Ni-Chun Tsai, Sandra H. Thomas, Tanya Paris, Leslie Popplewell, Chatchada Karanes, Tanya Siddiqi, Auayporn Nademanee, Ji-Lian Cai, Stephen J. Forman

Institutions: City Of Hope National Medical Center, City of Hope, Kaiser Permanente

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2254874203

FWCI: 0.669

Cites:

Cited by: 4

Related to: 10